赵敬国,倪彦君,孙婷,宋享福,马庆杰,李修义,高凤彤,杨巍.Egr-IFNγ基因治疗联合125I-脱氧尿嘧啶核苷治疗抑瘤效应的实验研究[J].中华放射医学与防护杂志,2008,28(6):606-608
Egr-IFNγ基因治疗联合125I-脱氧尿嘧啶核苷治疗抑瘤效应的实验研究
Anti-tumor effects of Egr-IFNγ gene therapy combined with 125I -UdR radionuclide therapy
投稿时间:2007-11-29  
DOI:
中文关键词:  γ干扰素  H22细胞  基因-放射性核素治疗  脱氧尿苷  碘放射性同位素
英文关键词:IFNγ  H22 cells  Gene-radiotherapy  Deoxyuridine  Iodine radioisotopes
基金项目:国家自然科学基金资助项目(30600160)
作者单位E-mail
赵敬国 116015 大连, 解放军第四零三医院  
倪彦君 沈阳军区总医院  
孙婷 吉林大学基础医学院生物化学教研室  
宋享福 吉林大学公共卫生学院  
马庆杰 吉林大学中日联谊医院  
李修义 吉林大学公共卫生学院  
高凤彤 吉林大学中日联谊医院  
杨巍 苏州大学放射医学与公共卫生学院放射生物教研室 detachedy@yahoo.com.cn 
摘要点击次数: 2977
全文下载次数: 1955
中文摘要:
      目的 探讨Egr-IFNγ基因治疗联合放射性核素 125I -脱氧尿嘧啶核苷治疗方案在荷H22肝癌细胞小鼠体内抑瘤效应及机制。方法 小鼠肿瘤局部注射脂质体包裹的质粒,注射后48 h,肿瘤局部注射370kBq 125I -UdR。观察各组小鼠治疗后不同时间肿瘤生长率;治疗后第3 天,检测肿瘤胞浆蛋白中IFNγ的表达和脾脏CTL细胞毒活性。结果 基因-放射核素治疗后第6~15天,pcDNAEgr-IFNγ+ 125I -UdR组肿瘤生长率明显低于对照组、 125I -UdR组及pcDNAEgr-1+ 125I -UdR 组;基因-放射性核素治疗后第3天,pcDNAEgr-IFNγ+ 125I -UdR组肿瘤胞浆蛋白中可检测到IFNγ的表达,其余组肿瘤胞浆蛋白中未检测到IFNγ的表达;pcDNAEgr-IFNγ+ 125I -UdR组小鼠脾脏CTL细胞毒活性明显高于其余组 (P<0.01)。结论 pcDNAEgr-IFNγ基因治疗联合放射性核素 125I -UdR治疗抑瘤效应明显优于单纯 125I -UdR放射性核素治疗。
英文摘要:
      Objective To explore the anti-tumor effects of Egr-IFNγ gene therapy combined with 125I-UdR radionuclide therapy in mice bearing H22 hepatocarcinoma and its mechanism.Methods The recombinant plasmid pcDNAEgr-IFNγ mixed with liposome was injected into tumor. 48 h later, 370 kBq 125I-UdR was injected into tumor. The tumor growth rates at different times were observed. After 3 d gene-radionuclide therapy, the concentration of IFNγ in cytoplasm of H22 cells and cytotoxic activities of splenic CTL of the mice in different groups were examined. Results The tumor growth rates of pcDNAEgr-IFNγ+ 125I -UdR group were obviously lower than those of control group, 125I -UdR group and pcDNAEgr-1+125I-UdR group 6-15d after gene-radionuclide therapy. IFNγ protein was found in cytoplasm of H22 cells in pcDNAEgr-IFNγ+125I-UdR group after 3 d gene-radionuclide therapy. Cytotoxic activity of splenic CTL in pcDNAEgr-IFNγ+125I-UdR group was significantly higher than that in the other groups (P<0.01). Conclusions The anti-tumor effects in vivo of pcDNAEgr-IFNγ gene therapy combined with 125I -UdR radionuclide therapy are better than those of 125I -UdR therapy.
HTML  查看全文  查看/发表评论  下载PDF阅读器
关闭